ENZI ABEBE: Open Payments
NPI 1497102214 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 45 payments from 6 companies in 2025. Trend: 2023 $2,373 · 2024 $1,829 · 2025 $1,276
Food & beverage: $1,264Education: $13
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 16 | $339 |
| Shionogi Inc | 9 | $269 |
| Melinta Therapeutics, LLC | 5 | $242 |
| ABBVIE INC. | 7 | $237 |
| Merck Sharp & Dohme LLC | 7 | $169 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: Fetroja, CABENUVA, Rezzayo, EMBLAVEO, PIFELTRO, ZERBAXA, AVYCAZ, DALVANCE.
Industry payments across NV — which companies pay providers there.
